Welcome to our dedicated page for Omada Health SEC filings (Ticker: OMDA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Omada Health, Inc. (Nasdaq: OMDA) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a virtual-first, between-visit healthcare provider focused on cardiometabolic and musculoskeletal conditions, Omada uses these filings to report on its financial condition, operations, and material events related to its digital chronic care platform.
Investors can review current reports on Form 8-K, which Omada uses to furnish press releases announcing quarterly results and other significant developments. For example, recent 8-K filings reference earnings press releases for periods in which the company reported revenue, member growth, and updates on its GLP-1-related offerings and AI capabilities. These current reports help readers connect headline financial and operational metrics to the underlying SEC record.
In addition to 8-Ks, Omada’s periodic reports on Form 10-Q and Form 10-K (accessible through the SEC and linked from this page when available) typically contain more detailed information on revenue composition, cost structure, research and development spending, and risks associated with its virtual care and GLP-1 programs. These filings are particularly relevant for understanding how Omada’s cardiometabolic and musculoskeletal programs, GLP-1 Care Tracks, and prescribing and medication management capabilities are reflected in its financial statements and risk disclosures.
Stock Titan enhances this information with AI-powered summaries that explain key points from lengthy filings, helping readers quickly identify sections related to Omada’s chronic care model, GLP-1 initiatives, and digital health operations. Users can also monitor updates to OMDA’s filings in near real time, including new 8-Ks, 10-Qs, 10-Ks, and other relevant forms, to follow how the company reports on its performance and material events over time.
Omada Health, Inc. Chief Accounting Officer Craig Gracey reported two open-market sales of common stock. On June 26, 2026, she sold 2,084 shares at $20.00 per share, followed by 2,083 shares at $21.00 per share on June 29, 2026, for a total of 4,167 shares sold. These transactions were executed under a Rule 10b5-1 trading plan adopted on March 13, 2026. After the sales, she directly holds 858 shares of Omada Health common stock.
Omada Health, Inc. Chief Financial Officer Steven L. Cook reported selling a total of 50,950 shares of common stock in late June 2026. He executed open-market sales of 33,000 shares at an average price of $19.8924 on June 26 and 17,950 shares at an average price of $21.0678 on June 29. After these sales, he directly holds 115,409 Omada Health shares. One transaction was carried out under a Rule 10b5-1 trading plan that Cook adopted on March 14, 2026, indicating the sale was pre-arranged rather than timed discretionarily.
OMDA filing a Form 144 reporting an intended sale of 300 shares of Common Stock on 06/30/2026 resulting from the exercise of stock options and to be sold for cash. The filing also lists multiple 10b5-1 sales by Steven Cook in June 2026.
The filing notifies of proposed sales of Common Stock by an affiliate under Form 144. It lists an exercise of stock options for 405 shares with cash consideration on 06/30/2026 and multiple 10b5-1 sale transactions attributed to Craig Gracey occurring in June 2026 with per-trade quantities and proceeds shown.
OMDA reports a proposed sale of Common Stock by Steven Cook. The filing lists multiple 10b5-1 sales and an exercise of stock options reported as securities to be sold on 06/29/2026 (17,950 shares, cash exercise). The excerpt also shows 10b5-1 sales including 06/26/2026 (33,000 shares) and earlier June trades.
OMDA: A Form 144 notice lists the proposed sale of 2,083 shares of Common Stock tied to the exercise of stock options with a cash transaction method, dated 06/29/2026. The filing also records multiple 10b5-1 sales by Craig Gracey on 06/12/2026, 06/22/2026, 06/24/2026, and 06/26/2026 with proceeds of $120,123.06, $37,494.00, $39,601.58, and $41,680.00, respectively.
Omada Health, Inc. Chief Executive Officer Sean P. Duffy reported open-market sales of an aggregate 17,258 shares of Common Stock on June 24–26, 2026. The reported sale prices ranged from $19.0033 to $20.9000 per share.
After these transactions, Duffy directly holds 394,603 shares of Omada Health common stock. In addition, 851,659 shares are held in family trusts for the benefit of his family members, and he disclaims beneficial ownership of those shares except to the extent of his pecuniary interest. The filing notes that the sales were made pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2026.
Omada Health, Inc. Chief Accounting Officer Craig Gracey reported an open-market sale of common stock. On June 24, 2026, she sold 2,083 shares at a weighted average price of $19.0118 per share. The transaction was made under a Rule 10b5-1 trading plan adopted on March 13, 2026, and she now directly holds 5,025 shares of Omada Health common stock.
Omada Health, Inc. Chief Financial Officer Steven L. Cook reported open-market sales of 2,900 shares of common stock on June 24–25, 2026, at weighted average prices around $19 per share. The transactions were made under a pre-arranged Rule 10b5-1 trading plan. Cook directly holds 166,359 shares after these sales.
OMDA filed a Form 144 announcing the proposed sale of 33,000 shares of Common Stock associated with an exercise of stock options to be effected on 06/26/2026. The filing lists a total dollar figure of $623,700.00 and identifies the transaction method as cash and the market as NASDAQ. The filing also discloses recent 10b5-1 sales by Steven Cook totaling individual transactions on 06/15/2026 (6,800 shares), 06/22/2026 (17,950 shares), 06/24/2026 (2,600 shares), and 06/25/2026 (300 shares).